FLUME Funding

 
 

Funding history

FLUME’s development has been made possible by a combination of investment by the founders, together with two rounds of Angel/ Friends & Family investment as well as grant support; an MRC funded Elizabeth Blackwell ‘Proof of Concept’ award and an NIHR ‘Research for Patient Benefit’ award to fund first in human evaluations at Bristol.

  • 2016-2019 Seed funding £450k

  • March 2020 Angel I £825k

  • March 2022 Angel II £2.1M

looking ahead

We would anticipate raising a Series A round in H1 2024.